Pfizer Jab Trials Data – What they wanted to hide for 75 Years
|
Getting your Trinity Audio player ready...
|
IT IS TIME TO FOLLOW THE SCIENCE
ThePlatform.ie – Ireland’s Solutions Resource
Pfizer Data Release
- Data Released under Freedom of Information Request on the Order of a Judge.
- 1,223 Deaths in the first 90 Days.
____________
Dr. Peter McCullough
- 50% of Deaths occurred within 48 hours.
- 80% within a week.
Dr. Naomi Wolf speaking on Team 5 Report on the Pfizer Data Release.
Pfizer Trial of 43,448 participants, age 16 years and older.
- 21,720 Received Pfizer BNT162b (Two-dose regimen of 30ug of Pfizer BNT162b)
- 21,728 Received a placebo.
“They (Pfizer) un-blinded the trial and ‘vaccinated’ the placebo group, so they got rid of the control group” Robert F. Kennedy, Jr. Chairman and Chief Legal Counsel of Children’s Health Defense.
- 20,761 of the 42,086 relevant cases are missing and were not followed up on and were not covered in the report.
- Half of the reports are incomplete.
- 71% were Female
- 22% were Male
- 7% No Gender
____________________
Q. Why only 22% male?
A. Myocarditis disproportionately occurs in males.
“Of the vaccinated people with myocarditis, 117 had myocarditis after the second dose of the Pfizer vaccine, compared with 19 after the first dose. Ninety-five people had age and sex data available, which showed that 91% were male and 76% were younger than 30 years.” https://www.cidrap.umn.edu/news-perspective/2021/10/covid-vaccine-related-myocarditis-rare-usually-mild-studies-say
Myocarditis and Pericarditis After mRNA COVID-19 Vaccination
Myocarditis is inflammation of the heart muscle, and pericarditis is inflammation of the outer lining of the heart. In both cases, the body’s immune system causes inflammation in response to an infection or some other trigger. Learn more about myocarditis and pericarditis. Seek medical care if you or your child have symptoms of these conditions after COVID-19 vaccination. Myocarditis and pericarditis have rarely been reported, especially in adolescents and young adult males within several days after COVID-19 vaccination.
Pfizer claimed 95% efficacy in ‘PREVENTING’ COVID-19 –
https://www.businesswire.com/news/home/20201210005703/en/
Pfizer’s own data has proved this to be completely untrue and dangerously deceptive.
It’s Time to Follow the Science.
Video (7 minutes) and Article by ChildrensHealthDefense.org
Peter McCullough, MD Testifies to Texas Senate Health & Human Services Committee.
Peter McCullough, MD Testifies to Texas Senate Health & Human Services Committee.
“Covid 19 has always been a treatable illness, A very large study from McKinney Texas and another from New York city show that when doctors treat patients early, who are over 50 with medical problems, with a sequence multi-drug approach with the available drugs, four to six drugs that are available to them, now monconal antibodies are better, there’s an 85 % reduction in hospitalisations and death, 85%.”
Drug companies, “mark their own homework”
Public Health and Medical Professionals for Transparency, Pfizer / FDA FOI
RISK OF HOSPITALISATION WITH HEART INFLAMMATION UP TO 44 TIMES HIGHER AFTER COVID VACCINE
A new study published in the peer-reviewed journal Nature has found that the risk of being hospitalised with heart inflammation can be up to 44 times higher following receipt of a double dose of Covid-19 mRNA vaccines.
The illusion of evidence based medicine
The illusion of evidence based medicine – Published by the British Medical Journal 16 March 2022
Evidence based medicine has been corrupted by corporate interests, failed regulation, and commercialisation of academia, argue these authors
https://www.bmj.com/content/376/bmj.o702
Is the FDA legit?
FDA asks for 55 years to review its Pfizer-BioNTech data before releasing to public
FDA asks for 55 years to review its Pfizer-BioNTech data before releasing to public
Congressman Introduces Bill to Force FDA to Release Pfizer Documents Within 100 Days, Instead of 55 Years
Why is the FDA funded in part by the companies it regulates?
The Food and Drug Administration has moved from an entirely taxpayer-funded entity to one increasingly funded by user fees paid by manufacturers that are being regulated. Today, close to 45% of its budget comes from these user fees that companies pay when they apply for approval of a medical device or drug.
